<p>ICU Medical（納斯達克代碼：ICUI - 獲取免費報告）在週四更新了其 2026 財年的收益指引。公司提供的每股收益指引為 7.750-8.450，而市場共識的每股收益預期為 7.740。公司發佈的收入指引為-。</p>
<h2>分析師升級與降級</h2>
<p>多家股票研究分析師對該股票發佈了報告。Piper Sandler 將 ICU Medical 的目標股價從 178.00 美元下調至 163.00 美元，並在 4 月 17 日的研究報告中給予該股票 “超配” 評級。KeyCorp 將 ICU Medical 的目標股價從 180.00 美元下調至 164.00 美元，並在 4 月 27 日的研究報告中給予該股票 “超配” 評級。Wall Street Zen 在 4 月 18 日的研究報告中將 ICU Medical 的評級從 “買入” 下調至 “持有”。最後，Weiss Ratings 在 1 月 22 日的研究報告中重申了對 ICU Medical 的 “賣出（d-）” 評級。一位分析師給予該股票 “強烈買入” 評級，兩位給予 “買入” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，平均目標價格為 169.00 美元。</p>
<p><strong>查看我們關於 ICU Medical 的最新股票報告</strong></p>
<h2>ICU Medical 價格表現</h2>
<p>週四，ICUI 股票上漲 3.48 美元，達到 123.07 美元。該公司交易了 351,997 股，較其平均交易量 275,739 股有所增加。該公司的 50 日移動平均線為 129.52 美元，200 日移動平均線為 138.31 美元。公司市值為 30.8 億美元，市盈率為 6,156.58，市盈率/增長比率為 1.69，貝塔值為 0.74。ICU Medical 的 12 個月低點為 107.00 美元，12 個月高點為 160.29 美元。公司的債務與股本比率為 0.60，流動比率為 2.39，速動比率為 1.15。</p>
<p>ICU Medical（納斯達克代碼：ICUI - 獲取免費報告）最近在 5 月 7 日發佈了季度收益數據。這家醫療器械供應商報告的每股收益（EPS）為 1.97 美元，超出分析師共識預期的 1.78 美元，超出幅度為 0.19 美元。該季度的收入為 5.2577 億美元，而分析師預期為 5.2065 億美元。ICU Medical 的淨利潤率為 0.03%，股本回報率為 7.33%。ICU Medical 已將其 2026 財年的指引設定為每股收益 7.750-8.450。整體來看，股票分析師預測 ICU Medical 在當前財年將發佈 6.31 美元的每股收益。</p>
<h2>ICU Medical 的機構交易</h2>
<p>幾家對沖基金最近調整了對 ICUI 的持股。Millennium Management LLC 在第三季度將其在 ICU Medical 的持股增加了 173.4%。Millennium Management LLC 現在擁有 1,089,017 股該醫療器械供應商的股票，價值 1.30638 億美元，此前在該期間又購買了 690,694 股。瑞銀集團（UBS Group AG）在第三季度將其在 ICU Medical 的持股增加了 239.8%。瑞銀集團現在擁有 386,555 股該醫療器械供應商的股票，價值 4,637.1 萬美元，此前在上個季度又購買了 272,782 股。Ameriprise Financial Inc.在第三季度將其在 ICU Medical 的持股增加了 34.0%。Ameriprise Financial Inc.現在擁有 803,542 股該醫療器械供應商的股票，價值 9,639.3 萬美元，此前在上個季度又購買了 203,746 股。Dimensional Fund Advisors LP 在第三季度將其在 ICU Medical 的持股增加了 16.9%。Dimensional Fund Advisors LP 現在擁有 872,993 股該醫療器械供應商的股票，價值 1.04718 億美元，此前在上個季度又購買了 126,072 股。最後，Janus Henderson Group PLC 在第四季度將其在 ICU Medical 的持股增加了 4.2%。Janus Henderson Group PLC 現在擁有 2,576,756 股該醫療器械供應商的股票，價值 3.67625 億美元，此前在該期間又購買了 103,220 股。機構投資者持有該公司 96.10% 的股份。</p>
<h2>ICU Medical 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>ICU Medical, Inc 及其子公司開發、製造和銷售用於輸液治療、血管通路和生命監護應用的醫療設備。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢設備；ChemoClave 和 ChemoLock 封閉系統轉移設備，用於限制有害藥物或蒸汽濃度的逸出，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 非穿刺針用於門靜脈通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，而非 ICU Medical</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 ICU Medical 嗎？</h2>
<p>在你考慮 ICU Medical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 ICU Medical 並不在名單上。</p>
<p>雖然 ICU Medical 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

ICU醫療

<p>ICU Medical (NASDAQ:ICUI) 更新了其 2026 財年的收益指引，預計每股收益在 7.750 到 8.450 之間，略高於市場共識預期的 7.740。該公司的股票表現上漲了 3.48 美元，達到 123.07 美元，市值為 30.8 億美元。分析師對該股票的評級不一，市場共識評級為 “適度買入”，平均目標價為 169.00 美元。機構投資者持有該公司 96.10% 的股份，反映出機構對 ICU Medical 的強烈興趣</p>

<p>ICU Medical (NASDAQ:ICUI - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 7.750-8.450 for the period, compared to the consensus earnings per share estimate of 7.740. The company issued revenue guidance of -.</p>
<div class="lb-trans"><p>ICU Medical（納斯達克代碼：ICUI - 獲取免費報告）在週四更新了其 2026 財年的收益指引。公司提供的每股收益指引為 7.750-8.450，而市場共識的每股收益預期為 7.740。公司發佈的收入指引為-。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級與降級</h2>
</div><p>A number of equities research analysts have issued reports on the stock. Piper Sandler reduced their price objective on shares of ICU Medical from $178.00 to $163.00 and set an &#34;overweight&#34; rating on the stock in a research note on Friday, April 17th. KeyCorp reduced their price objective on shares of ICU Medical from $180.00 to $164.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, April 27th. Wall Street Zen downgraded shares of ICU Medical from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, April 18th. Finally, Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of ICU Medical in a research note on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $169.00.</p>
<div class="lb-trans"><p>多家股票研究分析師對該股票發佈了報告。Piper Sandler 將 ICU Medical 的目標股價從 178.00 美元下調至 163.00 美元，並在 4 月 17 日的研究報告中給予該股票 “超配” 評級。KeyCorp 將 ICU Medical 的目標股價從 180.00 美元下調至 164.00 美元，並在 4 月 27 日的研究報告中給予該股票 “超配” 評級。Wall Street Zen 在 4 月 18 日的研究報告中將 ICU Medical 的評級從 “買入” 下調至 “持有”。最後，Weiss Ratings 在 1 月 22 日的研究報告中重申了對 ICU Medical 的 “賣出（d-）” 評級。一位分析師給予該股票 “強烈買入” 評級，兩位給予 “買入” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，平均目標價格為 169.00 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on ICU Medical</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 ICU Medical 的最新股票報告</strong></p>
</div><h2>ICU Medical Price Performance</h2>
<div class="lb-trans"><h2>ICU Medical 價格表現</h2>
</div><p>ICUI stock traded up $3.48 during trading on Thursday, reaching $123.07. 351,997 shares of the company were exchanged, compared to its average volume of 275,739. The company has a 50-day moving average of $129.52 and a two-hundred day moving average of $138.31. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of 6,156.58, a P/E/G ratio of 1.69 and a beta of 0.74. ICU Medical has a twelve month low of $107.00 and a twelve month high of $160.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.39 and a quick ratio of 1.15.</p>
<div class="lb-trans"><p>週四，ICUI 股票上漲 3.48 美元，達到 123.07 美元。該公司交易了 351,997 股，較其平均交易量 275,739 股有所增加。該公司的 50 日移動平均線為 129.52 美元，200 日移動平均線為 138.31 美元。公司市值為 30.8 億美元，市盈率為 6,156.58，市盈率/增長比率為 1.69，貝塔值為 0.74。ICU Medical 的 12 個月低點為 107.00 美元，12 個月高點為 160.29 美元。公司的債務與股本比率為 0.60，流動比率為 2.39，速動比率為 1.15。</p>
</div><p>ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.78 by $0.19. The business had revenue of $525.77 million during the quarter, compared to analyst estimates of $520.65 million. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, equities analysts predict that ICU Medical will post 6.31 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>ICU Medical（納斯達克代碼：ICUI - 獲取免費報告）最近在 5 月 7 日發佈了季度收益數據。這家醫療器械供應商報告的每股收益（EPS）為 1.97 美元，超出分析師共識預期的 1.78 美元，超出幅度為 0.19 美元。該季度的收入為 5.2577 億美元，而分析師預期為 5.2065 億美元。ICU Medical 的淨利潤率為 0.03%，股本回報率為 7.33%。ICU Medical 已將其 2026 財年的指引設定為每股收益 7.750-8.450。整體來看，股票分析師預測 ICU Medical 在當前財年將發佈 6.31 美元的每股收益。</p>
</div><h2>Institutional Trading of ICU Medical</h2>
<div class="lb-trans"><h2>ICU Medical 的機構交易</h2>
</div><p>Several hedge funds have recently modified their holdings of ICUI. Millennium Management LLC increased its position in shares of ICU Medical by 173.4% during the third quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier's stock valued at $130,638,000 after buying an additional 690,694 shares during the period. UBS Group AG boosted its stake in ICU Medical by 239.8% in the third quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier's stock worth $46,371,000 after buying an additional 272,782 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in ICU Medical by 34.0% in the third quarter. Ameriprise Financial Inc. now owns 803,542 shares of the medical instruments supplier's stock worth $96,393,000 after buying an additional 203,746 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in ICU Medical by 16.9% in the third quarter. Dimensional Fund Advisors LP now owns 872,993 shares of the medical instruments supplier's stock worth $104,718,000 after buying an additional 126,072 shares in the last quarter. Finally, Janus Henderson Group PLC boosted its stake in shares of ICU Medical by 4.2% during the fourth quarter. Janus Henderson Group PLC now owns 2,576,756 shares of the medical instruments supplier's stock valued at $367,625,000 after purchasing an additional 103,220 shares during the period. Institutional investors own 96.10% of the company's stock.</p>
<div class="lb-trans"><p>幾家對沖基金最近調整了對 ICUI 的持股。Millennium Management LLC 在第三季度將其在 ICU Medical 的持股增加了 173.4%。Millennium Management LLC 現在擁有 1,089,017 股該醫療器械供應商的股票，價值 1.30638 億美元，此前在該期間又購買了 690,694 股。瑞銀集團（UBS Group AG）在第三季度將其在 ICU Medical 的持股增加了 239.8%。瑞銀集團現在擁有 386,555 股該醫療器械供應商的股票，價值 4,637.1 萬美元，此前在上個季度又購買了 272,782 股。Ameriprise Financial Inc.在第三季度將其在 ICU Medical 的持股增加了 34.0%。Ameriprise Financial Inc.現在擁有 803,542 股該醫療器械供應商的股票，價值 9,639.3 萬美元，此前在上個季度又購買了 203,746 股。Dimensional Fund Advisors LP 在第三季度將其在 ICU Medical 的持股增加了 16.9%。Dimensional Fund Advisors LP 現在擁有 872,993 股該醫療器械供應商的股票，價值 1.04718 億美元，此前在上個季度又購買了 126,072 股。最後，Janus Henderson Group PLC 在第四季度將其在 ICU Medical 的持股增加了 4.2%。Janus Henderson Group PLC 現在擁有 2,576,756 股該醫療器械供應商的股票，價值 3.67625 億美元，此前在該期間又購買了 103,220 股。機構投資者持有該公司 96.10% 的股份。</p>
</div><h2>ICU Medical Company Profile</h2>
<div class="lb-trans"><h2>ICU Medical 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU Medical, Inc 及其子公司開發、製造和銷售用於輸液治療、血管通路和生命監護應用的醫療設備。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢設備；ChemoClave 和 ChemoLock 封閉系統轉移設備，用於限制有害藥物或蒸汽濃度的逸出，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 非穿刺針用於門靜脈通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than ICU Medical</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而非 ICU Medical</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in ICU Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 ICU Medical 嗎？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 ICU Medical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 ICU Medical 並不在名單上。</p>
</div><p>While ICU Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 ICU Medical 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

ICU Medical（NASDAQ:ICUI）更新 2026 財年盈利指引